Search details
1.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet
; 2024 May 16.
Article
in English
| MEDLINE | ID: mdl-38763154
2.
The future of cancer care in the UK-time for a radical and sustainable National Cancer Plan.
Lancet Oncol
; 25(1): e6-e17, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37977167
3.
Radiotherapy in metastatic bladder cancer.
World J Urol
; 42(1): 47, 2024 Jan 20.
Article
in English
| MEDLINE | ID: mdl-38244091
4.
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer.
World J Urol
; 42(1): 210, 2024 Apr 04.
Article
in English
| MEDLINE | ID: mdl-38573431
5.
Colorectal cancer health and care quality indicators in a federated setting using the Personal Health Train.
BMC Med Inform Decis Mak
; 24(1): 121, 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38724966
6.
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma.
Br J Cancer
; 128(12): 2307-2317, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37085598
7.
Current best practice for bladder cancer: a narrative review of diagnostics and treatments.
Lancet
; 400(10364): 1712-1721, 2022 11 12.
Article
in English
| MEDLINE | ID: mdl-36174585
8.
MRI-guided Pelvic Radiation Therapy: A Primer for Radiologists.
Radiographics
; 43(11): e230052, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37796729
9.
Prediction of prostate tumour hypoxia using pre-treatment MRI-derived radiomics: preliminary findings.
Radiol Med
; 128(6): 765-774, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37198374
10.
Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.
Int J Mol Sci
; 24(10)2023 May 18.
Article
in English
| MEDLINE | ID: mdl-37240301
11.
Radiotherapy respiratory motion management in hepatobiliary and pancreatic malignancies: a systematic review of patient factors influencing effectiveness of motion reduction with abdominal compression.
Acta Oncol
; 61(7): 833-841, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35611555
12.
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials.
Lancet Oncol
; 22(2): 246-255, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33539743
13.
A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer.
Br J Cancer
; 125(1): 85-93, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33846523
14.
The effect of hypoxia on PD-L1 expression in bladder cancer.
BMC Cancer
; 21(1): 1271, 2021 Nov 25.
Article
in English
| MEDLINE | ID: mdl-34819027
15.
Impact of hypoxia on cervical cancer outcomes.
Int J Gynecol Cancer
; 31(11): 1459-1470, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34593564
16.
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer.
BMC Urol
; 21(1): 96, 2021 Jul 01.
Article
in English
| MEDLINE | ID: mdl-34210300
17.
The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer.
World J Urol
; 37(9): 1767-1772, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-30218307
18.
Comparison of intensity modulated radiotherapy plan optimisation methods for a 1.5 T MR-Linac.
J Appl Clin Med Phys
; 20(1): 43-49, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30371972
19.
The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma.
Br J Cancer
; 118(5): 698-704, 2018 03 06.
Article
in English
| MEDLINE | ID: mdl-29235571
20.
The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004).
Br J Cancer
; 116(5): 649-657, 2017 Feb 28.
Article
in English
| MEDLINE | ID: mdl-28125821